Liposomal quercetin was demonstrated to attenuate bleomycin-induced pulmonary fibrosis in vivo by the suppression of inflammatory cytokines (TNF-α, IL-1β, and IL-6) and the diminish of total cells and macrophage counts in BALF. Here, IL1B is linked to pulmonary fibrosis.